SAGE Therapeutics Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest SAGE Therapeutics' careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

**Overview** **General Scope and Summary** The System Administrator’s role is to build and manage on-premises and cloud computer systems and network infrastructure to ensure high levels of availability and security of the supported b...
Posted: October 12, 2018, 9:29 am
**Overview** **General Scope and Summary** SAGE Therapeutics is seeking a Medical Director to oversee the planning and execution of clinical trials and the interpretation of clinical trial data. The successful candidate will be respo...
Posted: October 10, 2018, 8:38 am
**Overview** **General Scope and Summary** Sage is building a world-class Patient Support Services organization as it prepares to launch its first product into the Post-Partum Depression market. The case management team plays a key ...
Posted: October 10, 2018, 8:38 am
**Overview** **General Scope and Summary** SAGE Therapeutics is searching for a creative, resourceful, integrative thinker for ahighly visible role that is responsible forproviding the Commercial Organization with relevant, proactive...
Posted: October 6, 2018, 8:53 am
**Overview** **General Scope and Summary** SAGE Therapeutics is searching for a creative, resourceful, integrative thinker for ahighly visible role that is responsible forproviding the Commercial Organization with relevant, proactive...
Posted: October 6, 2018, 8:53 am

Viewing page 1 of 44|Next Page

  Newsfeed | Subscribe  

The medication called brexanolone, which is manufactured by Sage Therapeutics, is composed of a synthetic hormone related to the sex hormone progesterone. Progesterone is critical for brain health ...
Posted: October 5, 2018, 4:46 pm
In the first study, 45 women received 90 g/kg of brexanolone (Sage Therapeutics) per hour, 46 received 60 g/kg of brexanolone per hour, and 46 received placebo. Meltzer-Brody and colleagues reported t...
Posted: October 4, 2018, 7:36 am
CAMBRIDGE, Mass.--(Business Wire)--Sage Therapeutics (NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, ...
Posted: October 3, 2018, 4:03 am
Sage Therapeutics (NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on October 1 ...
Posted: October 2, 2018, 11:35 pm
Below is a chart showing COOL's trailing twelve month trading history, with the $15 strike highlighted in orange: Sage Therapeutics Inc (Symbol: SAGE) options are showing a volume of 1,170 contracts t...
Posted: September 10, 2018, 12:19 am

Viewing page 1 of 2|Next Page